» Articles » PMID: 34029379

Tumour Brain: Pretreatment Cognitive and Affective Disorders Caused by Peripheral Cancers

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2021 May 24
PMID 34029379
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

People that develop extracranial cancers often display co-morbid neurological disorders, such as anxiety, depression and cognitive impairment, even before commencement of chemotherapy. This suggests bidirectional crosstalk between non-CNS tumours and the brain, which can regulate peripheral tumour growth. However, the reciprocal neurological effects of tumour progression on brain homeostasis are not well understood. Here, we review brain regions involved in regulating peripheral tumour development and how they, in turn, are adversely affected by advancing tumour burden. Tumour-induced activation of the immune system, blood-brain barrier breakdown and chronic neuroinflammation can lead to circadian rhythm dysfunction, sleep disturbances, aberrant glucocorticoid production, decreased hippocampal neurogenesis and dysregulation of neural network activity, resulting in depression and memory impairments. Given that cancer-related cognitive impairment diminishes patient quality of life, reduces adherence to chemotherapy and worsens cancer prognosis, it is essential that more research is focused at understanding how peripheral tumours affect brain homeostasis.

Citing Articles

A broken circadian clock: The emerging neuro-immune link connecting depression to cancer.

Su K, Din Z, Cui B, Peng F, Zhou Y, Wang C Brain Behav Immun Health. 2022; 26:100533.

PMID: 36281466 PMC: 9587523. DOI: 10.1016/j.bbih.2022.100533.


The alterations in event-related potential responses to pain empathy in breast cancer survivors treated with chemotherapy.

Li W, Lv Y, Duan X, Cheng G, Yao S, Yu S Front Psychol. 2022; 13:942036.

PMID: 36211858 PMC: 9540992. DOI: 10.3389/fpsyg.2022.942036.


Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients.

Yen Y, Huang C, Chan H, Wang Y, Changchien T, Wang D J Pers Med. 2022; 12(8).

PMID: 35893308 PMC: 9331985. DOI: 10.3390/jpm12081213.


Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer.

Allemann-Su Y, Vetter M, Koechlin H, Paul S, Cooper B, Oppegaard K Cancers (Basel). 2022; 14(13).

PMID: 35805053 PMC: 9265628. DOI: 10.3390/cancers14133281.


Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.

Root J, Zhou X, Ahn J, Small B, Zhai W, Bethea T Breast Cancer Res Treat. 2022; 194(2):413-422.

PMID: 35587324 PMC: 9392482. DOI: 10.1007/s10549-022-06623-2.